ecropolis

Comparison of Two Methods for Sterilization of Filtering Facepiece Respirators Worn for Extended Periods During the COVID-19 Pandemic: An Experimental Laboratory Study | Real-world Effectiveness of Sotrovimab for the Treatment of SARS-CoV-2 Infection during Omicron BA.2 and BA.5 Subvariant Predominance: A Systematic Literature Review | Hospital Nurse Staffing Variation and COVID-19 Deaths: A Cross-sectional Study | Endothelial Dysfunction and Persistent Inflammation in Severe Post-COVID-19 Patients: Implications for Gas Exchange | Prevalence and Risk Factors of Cytomegalovirus Reactivation in Critically Ill Patients with COVID-19 Pneumonia | Epidemiologic Features of Recovery From SARS-CoV-2 Infection | Reduced olfactory bulb volume accompanies olfactory dysfunction after mild SARS-CoV-2 infection

Respiratory Syncytial Virus-Associated Hospitalizations in Children <5 Years: 2016–2022 | Nirsevimab Effectiveness Against Cases of Respiratory Syncytial Virus Bronchiolitis Hospitalised in Paediatric Intensive Care Units in France, September 2023–January 2024 | Neurodevelopmental Delay in Children Exposed to Maternal SARS-CoV-2 In-utero | COVID-19 is Associated with Early Emergence of Preeclampsia: Results from a Large Regional Collaborative | Effectiveness of Nirmatrelvir/ritonavir in Children and Adolescents Aged 12–17 Years Following SARS-CoV-2 Omicron Infection: A Target Trial Emulation | Nirmatrelvir-Ritonavir and Symptoms in Adults with Postacute Sequelae of SARS-CoV-2 Infection The STOP-PASC Randomized Clinical Trial

CDC Confirms Second Human H5 Bird Flu Case in Michigan; Third Case Tied to Dairy Outbreak | Relative Efficacy of Masks and Respirators as Source Control for Viral Aerosol Shedding from People Infected with SARS-CoV-2: A Controlled Human Exhaled Breath Aerosol Experimental Study | Early Use of Oral Antiviral Drugs and the Risk of Post COVID-19 Syndrome: A Systematic Review and Network Meta-analysis | Long-COVID Autonomic Syndrome in Working Age and Work Ability Impairment

Antibodies to Influenza A(H5N1) Virus in Hunting Dogs |
Cow’s Milk Containing Avian Influenza A(H5N1) Virus |
Risk Factors for Pediatric Critical COVID-19 |
The Risk of Aircraft-Acquired SARS-CoV-2 Transmission during Commercial Flights |
Durability of XBB.1.5 Vaccines against Omicron Subvariants |
Post-COVID Conditions Following COVID-19 Vaccination |
The Importance of Including Long COVID Outcomes When Developing Novel Treatments for Acute COVID-19 |
Cerebral Microstructural Alterations in Post-COVID-condition |
Prevalence and Co-occurrence of Cognitive Impairment in Children |
Long COVID Symptoms after 8-month Recovery

Estimates of SARS-CoV-2 Hospitalization and Fatality Rates in the Prevaccination Period |
Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 |
Cardiopulmonary Exercise Testing in Children with Long COVID |
Assessment of the Impact of RNase in Patients With Severe Fatigue Related to Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) |
Potential Diaphragm Muscle Weakness-related Dyspnea Persists Two Years after COVID-19

Virome Sequencing Identifies H5N1 Avian Influenza in Wastewater from Nine Cities | COVID-19 Vaccines and Adverse Events of Special Interest: A Multinational Global Vaccine Data Network (GVDN) Cohort Study of 99 million Vaccinated Individuals |
The Role of Colchicine in the Management of COVID-19: A Meta-analysis | Psychometric Analysis of the Modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) in a Prospective Multicentre Study

Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 | Association of Nirmatrelvir–ritonavir with Post-acute Sequelae and Mortality in Patients |
Effectiveness of Nirmatrelvir-Ritonavir for the Prevention of COVID-19–Related Hospitalization |
Cognitive Profile in Multiple Sclerosis and Post-COVID Condition | Unravelling the Mechanisms Behind Exercise Intolerance and Recovery in Long COVID |
Epidemiology of SARS-CoV-2 in Kakuma Refugee Camp Complex, Kenya, 2020-2021

COVID-19 Booster Vaccine Uptake and Reduced Risks for Long-COVID |
COVID-19 Immunologic Antiviral Therapy with Omalizumab (CIAO)—a Randomized Controlled Clinical Trial | Abatacept Pharmacokinetics and Exposure Response in Patients |
The Gut Microbiome Associates with Phenotypic Manifestations |
Characteristics and Determinants of Pulmonary Long COVID |
Long COVID: Plasma Levels of Neurofilament Light Chain in Mild COVID-19 Patients with Neurocognitive Symptoms